Wednesday, July 5th
  • About Us
  • Copyright
  • Disclaimer
  • Privacy Policy
  • Terms&Conditions
  • Contact Us
    • Advertisement
  • Site Map
Biosimilar News
  • Twitter
  • RSS
  • News/Headlines
  • Events
    • Upcoming Events
    • Past Events
  • Guidelines
  • Policies
  • Research/Analysis
USEFUL TIP: In order not to miss any updates, follow us on Twitter or sign up for our Newsletter..

Follow Us

  • Subscribe by RSS Subscribe by RSS
  • Contact us via E-Mail
  • Follow us on Twitter
  • Follow us on LinkedIn
 

Sign up for our newsletter

All-time Popular Posts

  • A biobetter trastuzumab is on the way A biobetter trastuzumab is on the way
  • EGA president calls on Member States to boost market access for biosimilars in the EU EGA president calls on Member States to boost market access for biosimilars in the EU
  • 3rd Forum on Biosimilars 3rd Forum on Biosimilars
  • Pfizer starts biosimilar rituximab Phase I/II trial Pfizer starts biosimilar rituximab Phase I/II trial
  • Indian Biosimilars Market Indian Biosimilars Market
  • World’s first biosimilar antibody* is approved in Korea World’s first biosimilar antibody* is approved in Korea
  • A biosimilar manufacturer: Celltrion A biosimilar manufacturer: Celltrion
  • 2 patents down, 1 to expire: Herceptin biosimilar coming to EU 2 patents down, 1 to expire: Herceptin biosimilar coming to EU

Archives

Twitter Updates

Archive for February, 2016

February 15, 2016 11:49 AM

EMA accepts Sandoz’s pegfilgrastim submission

February 15, 2016 11:21 AM

JHL Biotech receives approval from MHRA to begin biosimilar clinical trial

February 15, 2016 11:07 AM

Sandoz acquires Pfizer’s biosimilar infliximab in EEA

February 12, 2016 8:29 AM

Epirus initiates pivotal global Phase 3 study for BOW015 (infliximab biosimilar)

February 10, 2016 11:28 AM

FDA panel backs Celltrion and Pfizer’s Remicade (infliximab) biosimilar

February 8, 2016 10:01 AM

FDA backs Remicade biosimilar, Remsima in the United States

February 8, 2016 9:05 AM

EBG Biosimilars 2016 – 14th European Biosimilars Group Conference

© Copyright 2017 — Biosimilar News. All Rights Reserved Powered by Wordpress